Sometimes, the access gap is not a scientific or economic problem.
0 comments
No comments yet.
Related stories
- Zambia Approved an HIV Drug in 12 Daysasteriskmag.comHacker News · 3 points · 5 days ago
- Ars Technica · 0 points · 2 days ago
- Ars Technica · 0 points · 1 day ago
- Macrocyclic peptides: a new third drug class?empirical.healthHacker News · 2 points · 2 days ago
- Hacker News · 2 points · 7 days ago
- Hacker News · 2 points · 10 days ago